SEC Comment Letter 0000000000-25-003151 to MediWound Ltd. (MDWD)
MediWound Ltd.
Date: March 24, 2025 · CIK: 0001593984 · Accession: 0000000000-25-003151
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285908
Letter
Re: MediWound Ltd. Registration Statement on Form F-3 Filed March 19, 2025 File No. 333-285908 Dear Ofer Gonen:
March 24, 2025
Ofer Gonen Chief Executive Officer MediWound Ltd. 42 Hayarkon Street Yavne 8122745, Israel
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Michael J. Rosenberg, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 24, 2025 Ofer Gonen Chief Executive Officer MediWound Ltd. 42 Hayarkon Street Yavne 8122745, Israel Re: MediWound Ltd. Registration Statement on Form F-3 Filed March 19, 2025 File No. 333-285908 Dear Ofer Gonen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Michael J. Rosenberg, Esq. </TEXT> </DOCUMENT>